Reason for the update: New clinical data readout The most recent clinical data from NewAmsterdam Pharma (NASDAQ:NAMS) has showcased the potential of obicetrapib in...
U.S. stocks ended mostly higher on Monday as Treasury yields hit more multi-year highs and lawmakers averted a shutdown of the federal government over...
By Andrea Figueras French software company Planisware launched an initial public offering on Euronext Paris, setting an indicative price range that would result in...